A series of pathways, including the NF-κB, Nrf2, and TGF-β signaling pathways, are activated by major pathophysiological processes in DN such as hyperglycemia, oxidative stress, advanced glycation end products (AGEs), and angiotensin II. The gene discussed is TGFB1; the disease is liver dysplastic nodule.